相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
Chengzu Long et al.
SCIENCE (2016)
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar et al.
SCIENCE (2016)
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E. Nelson et al.
SCIENCE (2016)
Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells
Eszter Toth et al.
BIOLOGY DIRECT (2016)
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
Courtney S. Young et al.
CELL STEM CELL (2016)
CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
Li Xu et al.
MOLECULAR THERAPY (2016)
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA
Ines Fonfara et al.
NATURE (2016)
Generation of knockout mice by Cpf1-mediated gene targeting
Yongsub Kim et al.
NATURE BIOTECHNOLOGY (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Genome Editing of Monogenic Neuromuscular Diseases A Systematic Review
Chengzu Long et al.
JAMA NEUROLOGY (2016)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Viral vector-mediated gene therapies
Katrin Hollinger et al.
CURRENT OPINION IN NEUROLOGY (2015)
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran et al.
NATURE (2015)
MED13-dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver
Kedryn K. Baskin et al.
EMBO MOLECULAR MEDICINE (2014)
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Hao Yin et al.
NATURE BIOTECHNOLOGY (2014)
Chemically defined generation of human cardiomyocytes
Paul W. Burridge et al.
NATURE METHODS (2014)
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
Chengzu Long et al.
SCIENCE (2014)
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
Yuxuan Wu et al.
CELL STEM CELL (2013)
Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining
Marcello Maresca et al.
GENOME RESEARCH (2013)
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Foteini Mourkioti et al.
NATURE CELL BIOLOGY (2013)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
New connections between splicing and human disease
Richard A. Padgett
TRENDS IN GENETICS (2012)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
Brian Bostick et al.
MOLECULAR THERAPY (2011)
Total Skeletal Muscle PGC-1 Deficiency Uncouples Mitochondrial Derangements from Fiber Type Determination and Insulin Sensitivity
Christoph Zechner et al.
CELL METABOLISM (2010)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
Douglas P. Millay et al.
NATURE MEDICINE (2008)
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements
FJM Mojica et al.
JOURNAL OF MOLECULAR EVOLUTION (2005)
分享论文
